Cited by 340Proteoglycans and glycosaminoglycans researchProtease and Inhibitor MechanismsMechanisms of cancer metastasis

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Open access

Götte, Martin, Yip, George W.·2006·Cancer Research

DOI 10.1158/0008-5472.can-06-1464

Open this paper in CoChat — free account Open PDF

Abstract

Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. (Cancer Res 2006; 66(21): 10233-7)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-1464

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornélis, F., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,016
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
Bashkin, P., Doctrow, S. R., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Hortobágyi, G. N., Salazar, J. D. L. G., Pritchard, K. I., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H. M., Liu, M.-C., Martín, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586
Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 535
Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival
Auvinen, P., Tammi, R., Parkkinen, J. J., Tammi, M., Ågren, U. M., Johansson, R. T., Hirvikoski, P. P., Eskelinen, M. J., & Kosma, V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 494
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 491

Show all 58 references

Sorted by citations

Items 101–200 of 339

miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44
Zhao, H., Ma, B., Wang, Y., Han, T., Zheng, L., Sun, C., Liu, T., ZHANG, Y., Qiu, X., & Fan, Q. (2013) · Oncology Reports · doi:10.3892/or.2013.2234 · Cited by 72
CD 44‐Targeted Docetaxel Conjugate for Cancer Cells and Cancer Stem‐Like Cells: A Novel Hyaluronic Acid‐Based Drug Delivery System
Goodarzi, N., Ghahremani, M. H., Amini, M., Atyabi, F., Ostad, S. N., Ravari, N. S., Nateghian, N., & Dinarvand, R. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12288 · Cited by 69
Aptamer-based ATP-responsive delivery systems for cancer diagnosis and treatment
Sameiyan, E., Bagheri, E., Dehghani, S., Ramezani, M., Alibolandi, M., Abnous, K., & Taghdisi, S. M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.12.057 · Cited by 68
Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor Formation
Bohrer, L. R., Chuntova, P., Bade, L. K., Beadnell, T. C., Leon, R. P., Brady, N. J., Ryu, Y., Goldberg, J. E., Schmechel, S. C., Koopmeiners, J. S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2469 · Cited by 67
Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis
Zhang, J., Li, Y., Liu, H., Zhang, J., Wang, J., Jia Hui, X. I. A., Zhang, Y., Yu, X., Ma, J., Huang, M., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02242-3 · Cited by 67
Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas
Panagopoulos, A., Lancellotti, C. L. P., Veiga, J. C. E., de Aguiar, P. H. P., & Colquhoun, A. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9588-3 · Cited by 67
Reduction- and pH-Sensitive Hyaluronan Nanoparticles for Delivery of Iridium(III) Anticancer Drugs
Cai, Z., Zhang, H., Wei, Y. Z., Wei, Y., Xie, Y., & Cong, F. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00445 · Cited by 70
Breast Tumor Microenvironment: Proteomics Highlights the Treatments Targeting Secretome
Chen, S.-T., Pan, T., Juan, H., Chen, T., Lin, Y.-S., & Huang, C. (2008) · Journal of Proteome Research · doi:10.1021/pr700745n · Cited by 66
CD44/Cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients
Cheng, Y., Tao, L., Xu, J., Li, Q., Yu, J., Jin, Y., Chen, Q., Xu, Z., Zou, Q., & Liu, X. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22021 · Cited by 63
Targeting breast cancer stem cells through retinoids: A new hope for treatment
Jan, N., Sofi, S., Qayoom, H., Haq, B. U., Shabir, A., & Mir, M. A. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104156 · Cited by 62
pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery
Lin, J., Du, J., Yang, Y.-Q., Li, L., Zhang, D., Liang, C.-L., Wang, J., Mei, J., & Wang, G.-H. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.08.036 · Cited by 62
Cancer Stem Cell Marker CD44 Plays Multiple Key Roles in Human Cancers: Immune Suppression/Evasion, Drug Resistance, Epithelial–Mesenchymal Transition, and Metastasis
Dzobo, K., & Sinkala, M. (2021) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2021.0025 · Cited by 62
CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3‐CD44‐IGF2 signalling
Liu, Y., Yu, C.-H., Wu, Y., Sun, X., Su, Q., You, C., & Xin, H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13118 · Cited by 60
Phosphoinositide 3‐kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo
Teranishi, F., Takahashi, N., Gao, N., Akamo, Y., Takeyama, H., Manabe, T., & Okamoto, T. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01084.x · Cited by 60
Micro RNA regulation of proteoglycan function in cancer
Ibrahim, S., Hassan, H., & Götte, M. (2014) · FEBS Journal · doi:10.1111/febs.13026 · Cited by 62
New concepts in breast cancer metastasis: tumor initiating cells and the microenvironment
Sleeman, J. P., & Cremers, N. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9122-6 · Cited by 60
A Structural Analysis of Glycosaminoglycans from Lethal and Nonlethal Breast Cancer Tissues: Toward a Novel Class of Theragnostics for Personalized Medicine in Oncology?
Weyers, A. M., Yang, B., Yoon, D. S., Park, J., Zhang, F., Lee, K., & Linhardt, R. J. (2012) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2011.0102 · Cited by 58
PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
Hammond, E., Brandt, R., & Dredge, K. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052175 · Cited by 58
Tumor-Targeted Graphitic Carbon Nitride Nanoassembly for Activatable Two-Photon Fluorescence Imaging
Liu, J., Wang, Y., Zhang, C., Duan, L.-Y., Li, Z., Yu, R., & Jiang, J. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05192 · Cited by 58
Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells
Lim, D., Jocelyn, K. M.-X., Yip, G. W. C., & Bay, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.10.038 · Cited by 58
Self-citation
Amplified electrochemical detection of surface biomarker in breast cancer stem cell using self-assembled supramolecular nanocomposites
Zhao, J. T., Tang, Y., Cao, Y., Chen, T., Chen, X., Mao, X., Yin, Y., & Chen, G. (2018) · Electrochimica Acta · doi:10.1016/j.electacta.2018.07.002 · Cited by 57
CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients
Birzele, F., Voß, E., Nopora, A., Honold, K., Heil, F., Lohmann, S., Verheul, H. M. W., Tourneau, C. L., Delord, J., van Herpen, C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2141 · Cited by 56
Identification of a Panel of Genes as a Prognostic Biomarker for Glioblastoma
Wang, F., Zheng, Z., Guan, J., Qi, D., Zhou, S., Shen, X., Wang, F., Wenkert, D., Kirmani, B. F., Solouki, T., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.024 · Cited by 54
Proteases as modulators of tumor–stromal interaction: Primary tumors to bone metastases
Wilson, T. J., & Singh, R. K. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.11.001 · Cited by 53
Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
Wang, S., Shao, M., Zhong, Z., Wang, A., Cao, J., Lu, Y., Wang, Y., & Zhang, J. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1406558 · Cited by 53
Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms
Eccles, S. A., Paon, L., & Sleeman, J. P. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9123-5 · Cited by 53
Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer
Urakawa, H., Nishida, Y., Knudson, W., Knudson, C. B., Arai, E., Kozawa, E., Futamura, N., Wasa, J., & Ishiguro, N. (2011) · Journal of Orthopaedic Research® · doi:10.1002/jor.21557 · Cited by 52
Cancer Stem Cells and Metastasis
Nandy, S., & Lakshmanaswamy, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.007 · Cited by 50
Extracellular Molecules Involved in Cancer Cell Invasion
Stivarou, T., & Patsavoudi, E. (2015) · Cancers · doi:10.3390/cancers7010238 · Cited by 50
Current research on hyaluronic acid-drug bioconjugates
Zhang, H., Huang, S., Yang, X., & Zhai, G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.067 · Cited by 56
The biomimetic extracellular matrix: a therapeutic tool for breast cancer research
Tamayo-Angorrilla, M., de Andrés, J. L., Jiménez, G., & Marchal, J. A. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.008 · Cited by 51
shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells
Kim, H. (2011) · Oncology Reports · doi:10.3892/or.2011.1532 · Cited by 49
Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition
Chen, D., Lian, S., Sun, J., Liu, Z., Zhao, F., Jiang, Y., Gao, M., Sun, K., Liu, W., & Fu, F. (2014) · Drug Delivery · doi:10.3109/10717544.2014.917130 · Cited by 49
Protumorigenic Role of HAPLN1 and Its IgV Domain in Malignant Pleural Mesothelioma
Ivanova, A. V., Goparaju, C. M. V., Ivanov, S. V., Nonaka, D., Cruz, C., Beck, A. K., Lonardo, F., Wali, A., & Pass, H. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2755 · Cited by 50
Pigment Epithelium-derived Factor Binds to Hyaluronan
Becerra, S. P., Pérez‐Mediavilla, A., Weldon, J. E., Locatelli‐Hoops, S., Senanayake, P. D., Notari, L., Notario, V., & Hollyfield, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801287200 · Cited by 48
Self-assembling polymer systems for advanced treatment of cancer and inflammation
Palao‐Suay, R., Gómez‐Mascaraque, L. G., Aguilar, M. R., Vázquez‐Lasa, B., & Román, J. S. (2015) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2015.07.005 · Cited by 48
Novel Injectable Thermosensitive Hydrogels for Delivering Hyaluronic Acid–Doxorubicin Nanocomplexes to Locally Treat Tumors
Jhan, H.-J., Liu, J., Chen, Y., Liu, D.-Z., Sheu, M., & Ho, H. (2014) · Nanomedicine · doi:10.2217/nnm.14.211 · Cited by 47
Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles
Giarra, S., Serri, C., Russo, L., Zeppetelli, S., Rosa, G. D., Borzacchiello, A., Biondi, M., Ambrosio, L., & Mayol, L. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.12.031 · Cited by 47
Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer
Huang, C., Shen, C., Wang, H.-W., Wu, P., & Cheng, C. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.06.001 · Cited by 46
Modulation of hyaluronan production by CD44 positive glioma cells
Wiranowska, M., Ladd, S., Moscinski, L. C., Hill, B., Haller, E. M., Mikecz, K., & Plaas, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.25085 · Cited by 46
Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery
Dongsar, T. S., Dongsar, T. T., Molugulu, N., Annadurai, S., Wahab, S., Gupta, N., & Kesharwani, P. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116455 · Cited by 46
Perlecan‐rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor
Tsuneki, M., Cheng, J., Maruyama, S., Ida‐Yonemochi, H., Nakajima, M., & Saku, T. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2007.00620.x · Cited by 44
Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters
Petit, V., Massonnet, G., Maciorowski, Z., Touhami, J., Thuleau, A., Némati, F., Laval, J., Château‐Joubert, S., Servely, J., Vallerand, D., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.44 · Cited by 44
Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting Peptides
Yang, H., Liu, S., Cai, H., Wan, L., Li, S., Li, Y., Cheng, J., & Lu, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089417 · Cited by 43
Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis
Zhou, J., Nagarkatti, P. S., Yin, Z., & Nagarkatti, M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.002 · Cited by 44
CD44 targets Na+/H+ exchanger 1 to mediate MDA-MB-231 cells’ metastasis via the regulation of ERK1/2
Chang, G., Wang, J., Zhang, H., Zhang, Y., Wang, C.-X., Xu, H. Z., Zhang, H., Lin, Y., Ma, L., Li, Q., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.809 · Cited by 45
Activation of the innate immune system by the endogenous ligand hyaluronan
Shirali, A. C., & Goldstein, D. R. (2008) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3282f3df04 · Cited by 44
Engineered nanomaterials as an effective tool for HER2+ breast cancer therapy
Pandey, P. K., Arya, D. K., Ramar, M., Chidambaram, K., & Rajinikanth, P. S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.06.007 · Cited by 42
Transcriptome Profiling of a Multiple Recurrent Muscle-Invasive Urothelial Carcinoma of the Bladder by Deep Sequencing
Zhang, S., Liu, Y., Liu, Z., Zhang, C., Cao, H., Ye, Y., Wang, S., Zhang, Y., Xiao, S., Peng, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091466 · Cited by 42
Role of moesin in hyaluronan induced cell migration in glioblastoma multiforme
DeSouza, L. V., Matta, A., Karim, Z., Mukherjee, J., Wang, X. S., Krakovska, O., Zadeh, G. M., Guha, A., & Siu, K. M. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-74 · Cited by 42
Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity
Hashad, R. A., Ishak, R. A. H., Geneidi, A. S., & Mansour, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.008 · Cited by 42
Overcoming drug resistance with functional mesoporous titanium dioxide nanoparticles combining targeting, drug delivery and photodynamic therapy
Guo, Z., Zheng, K. C., Tan, Z., Liu, Y., Zhao, Z., Zhu, G., Ma, K., Cui, C., Wang, L., & Kang, T. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01810c · Cited by 42
Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer
Çelebiler, A., Kılıç, Y., Saydam, S., Canda, T., Başkan, Z., Sevınç, A. I., & Sakızlı, M. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01333.x · Cited by 42
Glycoproteomic analysis of two mouse mammary cell lines during transforming growth factor (TGF)-beta induced epithelial to mesenchymal transition
Hill, J. J., Tremblay, T., Cantin, C., O'Connor‐McCourt, M. D., Kelly, J. F., & Lenferink, A. E. G. (2009) · Proteome Science · doi:10.1186/1477-5956-7-2 · Cited by 41
Role of microglia in the process of inflammation in the hypoxic developing brain
Yi, Y. D. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/194 · Cited by 41
Aspects of Collagen Changes in Breast Cancer
Luparello, C. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s13-007 · Cited by 43
An antisense transcript mediates MALAT1 response in human breast cancer
Gomes, C. P., Pereira, S. N., Domingues-Silva, B., Rebelo, K., Alves‐Vale, C., Marinho, S. P., Carvalho, T., Dias, S., & de Jesus, B. B. (2019) · BMC Cancer · doi:10.1186/s12885-019-5962-0 · Cited by 41
Identification of CD44 as a Surface Biomarker for Drug Resistance by Surface Proteome Signature Technology
Cain, J. W., Hauptschein, R. S., Stewart, J. K., Onder, T. B., Sahagian, G. G., & Jay, D. G. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0237 · Cited by 40
Is Breast Augmentation Using Hyaluronic Acid Safe?
McCleave, M. J. (2009) · Aesthetic Plastic Surgery · doi:10.1007/s00266-009-9450-9 · Cited by 40
CD 44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus‐positive patients with resected hepatocellular carcinoma
Kakehashi, A., Ishii, N., Sugihara, E., Gi, M., Saya, H., & Wanibuchi, H. (2016) · Cancer Science · doi:10.1111/cas.12908 · Cited by 39
Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation
Choi, H. S., Kim, J. H., Kim, S., & Lee, D. (2019) · Cells · doi:10.3390/cells8091007 · Cited by 39
Hyaluronic acid-functionalized halloysite nanotubes for targeted drug delivery to CD44-overexpressing cancer cells
Mo, X., Wu, F., Li, Y., & Cai, X. (2021) · Materials Today Communications · doi:10.1016/j.mtcomm.2021.102682 · Cited by 39
Functional Screen of Paracrine Signals in Breast Carcinoma Fibroblasts
Su, G., Sung, K. E., Beebe, D. J., & Friedl, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046685 · Cited by 40
Efficient CD44-targeted magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid (HA)-modified MnFe2O4 nanocrystals
Lee, T., Lim, E., Lee, J., Kang, B., Choi, J., Park, H. S., Suh, J., Huh, Y., & Haam, S. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-149 · Cited by 39
DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis
Wallach‐Dayan, S. B., Rubinstein, A. M., Hand, C., Breuer, R., & Naor, D. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2383 · Cited by 38
A hybrid model for cell proliferation and migration in glioblastoma
Kim, Y., & Roh, S. (2013) · Discrete and Continuous Dynamical Systems - B · doi:10.3934/dcdsb.2013.18.969 · Cited by 39
Involvement of Syndecan-1 and Heparanase in Cancer and Inflammation
Teixeira, F. C. O. B., & Götte, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_4 · Cited by 38
Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid
Dickinson, L. E., Ho, C. C. M., Wang, G. M., Stebe, K. J., & Gerecht, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.044 · Cited by 38
The APE1 redox inhibitor E3330 reduces collective cell migration of human breast cancer cells and decreases chemoinvasion and colony formation when combined with docetaxel
Guerreiro, P. S., Corvacho, E., Costa, J. G., Saraiva, N., Fernandes, A. S., Castro, M., Miranda, J. P., & Oliveira, N. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12979 · Cited by 36
Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors
Mori (2009) · Oncology Reports · doi:10.3892/or_00000603 · Cited by 37
Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications
Müller, I., Wischnewski, F., Pantel, K., & Schwarzenbach, H. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-297 · Cited by 37
Non-coding RNAs in lung cancer
Ricciuti, B., Mecca, C., Crinò, L., Baglivo, S., Cenci, M., & Metro, G. (2014) · Oncoscience · doi:10.18632/oncoscience.98 · Cited by 38
Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma
Choi, G. H., Kim, G. I., Yoo, J. E., Na, D. C., Han, D. H., Roh, Y. H., Park, Y. N., & Choi, J. S. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4480-9 · Cited by 36
MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior
Ibrahim, S., Hassan, H., & Götte, M. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.01.022 · Cited by 37
Attenuation of Tumor Growth by Formation of Antiproliferative Glycosaminoglycans Correlates with Low Acetylation of Histone H3
Nilsson, U., Johnsson, R. E., Fransson, L., Ellervik, U., & Mani, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4331 · Cited by 36
Reversing Cancer Multidrug Resistance in Xenograft Models via Orchestrating Multiple Actions of Functional Mesoporous Silica Nanoparticles
Yang, D., Wang, T., Su, Z., Xue, L., Mo, R., & Zhang, C. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04885 · Cited by 35
Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells
Liang, G., Li, S., Du, W., Ke, Q., Cai, J., & Yang, J. (2016) · Oncology Letters · doi:10.3892/ol.2016.5473 · Cited by 36
TLR4 Polymorphisms and Expression in Solid Cancers
Pandey, N. O., Chauhan, A. V., & Jain, N. D. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0361-9 · Cited by 36
The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7
Fang, X., Jiang, H., Zhao, X. P., & Jiang, W. M. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-290 · Cited by 35
CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma
Gerardo‐Ramírez, M., Keggenhoff, F. L., Giam, V., Becker, D., Groth, M., Hartmann, N., Straub, B. K., Morrison, H., Galle, P. R., Marquardt, J. U., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158616 · Cited by 35
Development of a Biosensor for Detection of Pleural Mesothelioma Cancer Biomarker Using Surface Imprinting
Mathur, A., Blais, S. P., Goparaju, C. M. V., Neubert, T. A., Pass, H. I., & Levón, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057681 · Cited by 34
C-type lectins facilitate tumor metastasis
Ding, D., Yao, Y., Zhang, S., Su, C., & Zhang, Y. (2016) · Oncology Letters · doi:10.3892/ol.2016.5431 · Cited by 34
Polysaccharide-Based Biomaterials for Protein Delivery
Wang, K., Liu, M., & Mo, R. (2020) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2020.100031 · Cited by 34
Tamoxifen Induces Heparanase Expression in Estrogen Receptor–Positive Breast Cancer
Cohen, I., Maly, B., Simon, I., Meirovitz, A., Pikarsky, E., Zcharia, E., Peretz, T., Vlodavsky, I., & Elkin, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2546 · Cited by 34
Serum hyaluronic acid and laminin as potential tumor markers for upper gastrointestinal cancers
Aghcheli, K., Parsian, H., Qujeq, D., Talebi, M. J., Mosapour, A., Khalilipour, E., Islami, F., Semnani, S., & Malekzadeh, R. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.07.018 · Cited by 34
Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity
Quan, H., Zhu, F., Han, X., Xu, Z., Zhao, Y., & Miao, Z. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.02.018 · Cited by 34
Hyaluronan in Breast Cancer: Correlations With Nitric Oxide Synthases and Tyrosine Nitrosylation
Karihtala, P., Soini, Y., Auvinen, P., Tammi, R., Tammi, M., & Kosma, V. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7270.2007 · Cited by 34
Global Quantitative Phosphoproteome Analysis of Human Tumor Xenografts Treated with a CD44 Antagonist
Weigand, S., Herting, F., Maisel, D., Nopora, A., Voß, E., Schaab, C., Klammer, M., & Tebbe, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0136 · Cited by 34
Detection of the 1H and 15N NMR Resonances of Sulfamate Groups in Aqueous Solution: A New Tool for Heparin and Heparan Sulfate Characterization
Langeslay, D. J., Béni, S., & Larive, C. K. (2011) · Analytical Chemistry · doi:10.1021/ac202144m · Cited by 33
Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
Srinivasan, D., Senbanjo, L. T., Majumdar, S., FRANKLIN, R. B., & Chellaiah, M. A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27573 · Cited by 33
Artificial intelligence-driven pan-cancer analysis reveals miRNA signatures for cancer stage prediction
Sathipati, S. Y., Tsai, M., Shukla, S. K., & Ho, S. (2023) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100190 · Cited by 33
Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells
Kim, S., Kil, W. H., Lee, J., Oh, S. J., Han, J., Jeon, M., Jung, T., Lee, S. K., Bae, S. Y., Lee, H., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3514 · Cited by 33
4-Methylumbelliferone leads to growth arrest and apoptosis in canine mammary tumor cells
Saito, T., Tamura, D., NAKAMURA, T., MAKITA, Y., ARIYAMA, H., KOMIYAMA, K., YOSHIHARA, T., & Asano, R. (2012) · Oncology Reports · doi:10.3892/or.2012.2100 · Cited by 32
Expression of CD44 Is Associated with a Metastatic Pattern of Human Neuroblastoma Cells in a SCID Mouse Xenograft Model
Valentiner, U., Valentiner, F.-U., & Schumacher, U. (2008) · Tumor Biology · doi:10.1159/000143401 · Cited by 32
Hyaluronan in cancer – from the naked mole rat to nanoparticle therapy
Rankin, K. S., & Frankel, D. J. (2016) · Soft Matter · doi:10.1039/c6sm00513f · Cited by 32
Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity
Kim, W. S., Kim, H., Kwon, K. W., Im, S., Lee, B. R., Ha, S., & Shin, S. J. (2016) · Oncotarget · doi:10.18632/oncotarget.9260 · Cited by 32
Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities
Nguyen, N., Kumar, A., Chacko, S. M., Ouellette, R. J., & Ghosh, A. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0204-z · Cited by 33
Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells
Vitale, D. L., Caon, I., Parnigoni, A., Sevic, I., Spinelli, F. M., Icardi, A., Passi, A. G., Vigetti, D., & Alaniz, L. D. (2021) · Biomolecules · doi:10.3390/biom11020246 · Cited by 31
MARCH8 Suppresses Tumor Metastasis and Mediates Degradation of STAT3 and CD44 in Breast Cancer Cells
Chen, W., Patel, D. B., Jia, Y., Yu, Z., Liu, X., Shi, H., & Liu, H. (2021) · Cancers · doi:10.3390/cancers13112550 · Cited by 31
Ethyl Acetate Extract of Colletotrichum gloeosporioides Promotes Cytotoxicity and Apoptosis in Human Breast Cancer Cells
Rai, N., Gupta, P., Verma, A. K., Tiwari, R. K., Madhukar, P., Kamble, S. C., Kumar, A., Kumar, R., Singh, S. K., & Gautam, V. (2023) · ACS Omega · doi:10.1021/acsomega.2c05746 · Cited by 31

Authors: Götte, M., & Yip, G. W.
Affiliations: 1Department of Obstetrics and Gynecology, Münster University Hospital, Münster, Germany and
National University of Singapore (SG)
ORCID: Yip, George W.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2006-11-01
Volume: 66
Issue: 21
Pages: 10233-10237
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-06-1464
OpenAlex: W2134709252
Cited by: 340
References: 58
Citations by year: 2026: 3 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 22 · 2016: 22 · 2015: 19 · 2014: 25 · 2013: 28 · 2012: 24
FWCI: 1.57
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
Funders: Deutsche Forschungsgemeinschaft
Medical Research Council
National Medical Research Council
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: heparanase, hyaluronic acid, CD44, breast cancer, glycosaminoglycans, tumor microenvironment, tumor stroma, metastasis, tumor progression, angiogenesis, tumor cell proliferation, cell migration and invasion, prognostic factors, therapeutic target
MeSH terms: Heparanase, Breast Neoplasms, Female, Glucuronidase, Humans, Hyaluronic Acid, Neoplasm Invasiveness, Hyaluronan Receptors, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks